W. Birkmayer And NotIsraël
List of bibliographic references
Number of relevant bibliographic references: 13.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 002821 | W. Birkmayer [Autriche] ; G. J. D. Birkmayer [Autriche] | Strategy and tactic of modern Parkinson therapy |
| 002822 | G. J. D. Birkmayer [Autriche] ; W. Birkmayer [Autriche] | Stimulation of endogenous L‐dopa biosynthesis — a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH) |
| 002967 | W. Birkmayer [Autriche] ; D. Birkmayer [Autriche] | Iron, a new aid in the treatment of Parkinson patients |
| 002C33 | P. Riederer [Autriche] ; W. Birkmayer [Autriche] ; D. Seemann [Autriche] ; St. Wuketich [Autriche] | Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome |
| 002C56 | W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; H. Youdim [Autriche] ; W. Linauer [Autriche] | The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil |
| 002C69 | W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | Nucleus ruber and L-Dopa psychosis: Biochemical post-mortem findings |
| 002C82 | H. Bernheimer ; W. Birkmayer ; O. Hornykiewicz ; K. Jellinger ; F. Seitelberger | Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations |
| 002C83 | W. Birkmayer [Autriche] ; W. Danielcyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | L-dopa level in plasma, primary condition for the kinetic effect |
| 002C95 | W. Birkmayer [Autriche] ; W. Danielczyk [Autriche] ; E. Neumayer [Autriche] ; P. Riederer [Autriche] | The balance of biogenic amines as condition for normal behaviour |
| 002D01 | W. Birkmayer [Autriche] ; E. Neumayer [Autriche] | Die moderne medikamentöse Behandlung des Parkinsonismus |
| 002D39 | W. Birkmayer [Autriche] ; M. Mentasti [Autriche] | Weitere experimentelle Untersuchungen über den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom) |
| 002D45 | W. Birkmayer [Allemagne] ; O. Hornykiewicz [Allemagne] | Der L-Dioxyphenylalanin (=L-DOPA)-Effekt beim Parkinson-Syndrom des Menschen: Zur Pathogenese und Behandlung der Parkinson-Akinese |
| 002D51 | W. Birkmayer [Allemagne] ; O. Hornykiewicz [Allemagne] | Weitere experimentelle Untersuchungen über L-DOPA beim Parkinson-Syndrom und Reserpin-Parkinsonismus |
| This area was generated with Dilib version V0.6.23. |  |